Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Clinical trial NCT06280495 · RECRUITING
Trial details
- NCT number
- NCT06280495
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-12-31
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.